Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. 1996

W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
Department of Medicine, University of Maryland Medical School, Baltimore 21201, USA.

In allergic asthma, inhalation of antigen provokes an early increase in microvascular permeability with protein extravasation and a delayed recruitment of inflammatory cells. We showed that similar concentrations of lipopolysaccharide (LPS) are present in bronchoalveolar lavage fluid (BALF) in 12 subjects without asthma (86.5 +/- 53.8 pg/ml) and 12 subjects with mild asthma (111 +/- 37.0 pg/ml). These LPS levels are insufficient to stimulate cytokine release without accessory molecules. BALF obtained 24 h after segmental ragweed antigen challenge in 11 asthmatics allergic to ragweed contained increased levels of two LPS accessory molecules compared with preantigen BALF, 158-fold more LPS-binding protein (LBP) 4.83 +/- 2.02 vs. 742 +/- 387 ng/ml; P < 0.03) and 31.6-fold more soluble CD14 (sCD14) (3.45 +/- 1.04 vs. 110 +/- 51.6 ng/ml; P < 0.02). Postantigen BALF enhanced binding of fluorescein-conjugated LPS to CD14-bearing THP-1 cells and supported LPS-induced non-CD14-bearing endothelial cell expression of intercellular adhesion molecule-1 and interleukin-6, indicating functional LBP and sCD14. We suggest that extravasation of LBP and sCD14 into the bronchoalveolar compartment after antigen inhalation may enhance the capacity of inhaled or aspirated LPS to activate an inflammatory cascade that may amplify the inflammatory response to inhaled antigen in some asthmatics.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000209 Acute-Phase Proteins Proteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers. Acute Phase Reactant,Acute-Phase Glycoprotein,Acute-Phase Reactant,Acute-Phase Reactants,Proteins, Acute-Phase,Reactants, Acute-Phase,Acute-Phase Glycoproteins,Acute-Phase Protein,Acute Phase Glycoprotein,Acute Phase Glycoproteins,Acute Phase Protein,Acute Phase Proteins,Acute Phase Reactants,Glycoprotein, Acute-Phase,Glycoproteins, Acute-Phase,Phase Reactant, Acute,Protein, Acute-Phase,Proteins, Acute Phase,Reactant, Acute Phase,Reactant, Acute-Phase,Reactants, Acute Phase
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
May 1995, The Journal of biological chemistry,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
March 1994, Chest,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
January 1997, The Journal of clinical investigation,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
September 1997, The Journal of biological chemistry,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
May 2010, Japanese journal of ophthalmology,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
June 2007, Intensive care medicine,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
February 2009, The European respiratory journal,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
June 1995, Journal of immunology (Baltimore, Md. : 1950),
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
February 2006, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue,
W Dubin, and T R Martin, and P Swoveland, and D J Leturcq, and A M Moriarty, and P S Tobias, and E R Bleecker, and S E Goldblum, and J D Hasday
April 1993, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!